Thursday, 26 May 2016

Nifty eyes 8150, Sensex firm; Sun Pharma soars 4%, ITC down

Epic Update Sun PharmaceuticalEpic Update Sun Pharmaceutical

Equity benchmarks continued to see buying interest on first day of June series. The Nifty is inching towards 8150 level, up 55.65 points or 0.69 percent at 8125.30.

The Sensex rose 168.30 points or 0.64 percent to 26534.98, led by pharma, banks and technology stocks. The broader markets also participated in rally with the BSE Midcap and Smallcap indices rising 0.7 percent each. The market breadth remained strong as about two shares advanced for every share declining on Bombay Stock Exchange.

Sun Pharma surged 4 percent after Taro earnings. Its subsidiary’s profit declined 24.5 percent but operational performance was strong due to a 16.4 percent fall in R&D cost. Operating margin expanded by 400 basis points at 69 percent YoY.

Lupin gained nearly 3 percent after sources told CNBC-TV18 that Mandideep unit has received establishment inspection report from US FDA. It is the 2nd largest revenue contributor to US business after Goa unit.

ITC, Tata Motors, L&T and NTPC were marginally down on profit booking.

For more information and best STOCK TIPS Call us ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH
Connect with our social media sites 
Facebook Twitter YouTube Pinterest Linkedin Google+

0 comments:

Post a Comment

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Online Project management